Role of the central histaminergic neuronal system in the CNS toxicity of the first generation H1-antagonists

Progress in Neurobiology

Volumn 52, Issue 2, 1997, Pages 145-157

  Sangalli, Bernard C ^a  

^a Phelps Memorial Hospital Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBINOXAMINE; CHLORPHENIRAMINE; CYCLIZINE; CYPROHEPTADINE; DIPHENHYDRAMINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; IMIPRAMINE; KETOTIFEN; LYSERGIDE; MEPYRAMINE; METODICLOROFEN; MUSCARINIC M1 RECEPTOR; PROMETHAZINE; SEROTONIN 2 RECEPTOR; TRIPELENNAMINE; TRIPROLIDINE;

ANTICHOLINERGIC EFFECT; BRAIN ELECTROPHYSIOLOGY; DRUG RECEPTOR BINDING; HALLUCINATION; HUMAN; NEUROMODULATION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; REVIEW; SEIZURE; THALAMUS;

EID: 0030905753     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(97)00011-7     Document Type: Article

References (145)

1. Aghajanian, G. K., Foote, W. E. and Sheard, M. H. (1968) Lysergic acid diethylamide: Sensitive neuronal units in the midbrain raphe. Science 161, 706-708.
2. Aghajanian, G. K. and Lakoski, J. M. (1976) Hyperpolarization of serotonergic neurons by serotonin and LSD: studies in brain slices showing increased K + conductance. Brain Res. 305, 181-185.
3. Arrang, J. M., Devaux, B., Chodkiewicz, J. P. and Schwartz, J. C. (1988a) H3-receptors control histamine release in human brain. J. Neurochem. 7;51(1):105-8.
4. Arrang, J. M., Defontaine, N. and Schwartz, J. C. (1988b) Phencyclidine blocks histamine H3-receptors in rat brain. Eur. J. Pharmacol. 157, 31-35.
5. Asaad, G. and Shapiro, B. (1986) Hallucinations: theoretical and clinical overview. Am. J. Psychiatry 143, 1088-1097.
6. Baba, M., Nishibori, M., Oishi, R., Saeki, K. and Kosaka, F. (1987) Effects of halothane, enflurane and pentobarbital on brain histamine dynamics in mice. Naunyn-Schmiedebergs. Arch. Pharmac. 335, 686-691.
7. Bal, T. and McCormick, D. A. (1993) Mechanisms of oscillatory activity in guinea-pig nucleus reticularis thalami in vitro: a mammalian pacemaker. J. Physiol. (Lond) 468, 669-691.
8. Bekkers, J. M. (1993) Enhancement by histamine of NMDA-mediated synaptic transmission in the hippocampus. Science 261, 104-106.
9. Buckley, N. A., Whyte, I. M., Dawson, A. H. and Cruickshank, D. A. (1994) Pheniramine - a much abused drug. Med. J. Aust. 160, 188-192.
10. Buzsaki, G., Smith, A., Berger, S., Fischer, L. J. and Gage, F. H. (1990) Petit mal epilepsy and parkinsonian tremor: hypothesis of a common pacemaker. Neuroscience 36, 1-14.
11. Chen, G., Ensor, C. R. and Portman, R. (1953) Comparison of the anticonvulsant properties of phenytoin, mephensin and benadryl. Fed. Proc. 12, 309.
12. Cheng, Y. C. and Prusoff, W. H. (1973) Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmac. 22, 3099-3108.
13. Churchill, J. A. and Gammon, G. D. (1949) The effect of antihistaminic drugs on convulsive seizures. J. Am. Med. Assoc. 141, 18-21.
14. Cockrell, J. L. (1987) Acute hallucinogenic reaction to carbinoxamine maleate. J. Tox. Clin. Tox. 25, 161-167.
15. Connors, B. W. (1984) Initiation of synchronized neuronal bursting in neocortex. Nature 310, 685-687.
16. DeBacker, M. D., Gommeren, W., Moereels, H., Nobels, G., Van Gompel, P., Leysen, J. E. and Luyten, W. H. (1993) Genomic cloning, heterologous expression and pharmacological characterization of a human histamine H1 receptor. Biochem. Biophys. Res. Commun. 197, 1601-1608.
17. Destexhe, A., McCormick, D. A. and Sejnowski, T. J. (1993) A model for 8-10 Hz spindling in interconnected thalamic relay and reticularis neurons. Biophys. J. 65, 2473-2477.
18. Fink, M. (1969) EEG and human psychopharmacology. Ann. Rev. Pharm. 9, 241-258.
19. Foehring, R. C. and Wyler, A. R. (1990) Two patterns of firing in human neocortical neurons. Neuroscience Lett. 110, 279-285.
20. Foehring, R. C. and Waters, R. S. (1991) Contributions of low-threshold calcium current and anomalous rectifier (Ih) to slow depolarizations underlying burst firing in human neocortical neurons in vitro. Neuroscience Lett. 124, 17-21.
21. Foehring, R. C., Lorenzon, N. M., Herron, P. and Wilson, C. J. (1991) Correlation of physiologically and morphologically identified neuronal types in human association cortex in vitro. J. Neurophysiology 66, 1825-1837.
22. Fredrickson, P. A. and Richelson, E. (1979) Hallucinogens antagonize histamine H-1 receptors of cultured mouse neuroblastoma cells. Eur. J. Pharmacol. 56, 261-264.
23. Gellman, R. L. and Aghajanian, G. K. (1994) Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: antagonism by atypical antipsychotic drugs. Neurosci. 58, 515-525.
24. Gerber, U., Greene, R. W., McCarley, R. W. and Haas, H. L. (1990) Excitation of brain stem neurons by noradrenaline and histamine. J. Basic Clin. Physiology Pharmacol. 1, 71-76.
25. Glennon, R. A. (1990) Do classical hallucinogens act as 5-HT2 agonists or antagonists?. Neuropsychopharmac. 3, 509-517.
26. Gloor, P. and Fariello, R. G. (1988) Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy. Trends Neurosci. 11, 63-68.
27. Goldstein, L., Murphree, H. B. and Pfeiffer, C. C. (1968) Comparative study of EEG effects of antihistamines in normal volunteers. J. Clin. Pharmac. 8, 42-53.
28. Gott, P. H. (1968) Cyclizine toxicity - intentional drug abuse of a proprietary antihistamine. N. Eng. J. Med. 279, 596.
29. Gray, C. M. and McCormick, D. A. (1996) Chattering cells: superficial pyramidal neurons contributing to the generation of synchronous oscillations in the visual cortex. Science 274, 109-113.
30. Green, J. P., Johnson, C. L., Weinstein, H. and Maayani, S. (1977) Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide. Proc. Natl. Acad. Sci U.S.A. 74, 5697-5701.
31. Green, J. P., Maayani, S., Weinstein, H. and Hough, L. B. (1980) Histamine and psychotropic drugs. Psychopharmac. Bull. 16, 36-38.
32. Gulat-Marnay, C., Lafitte, A., Arrang, J. M. and Schwartz, J. C. (1989a) Regulation of histamine release and synthesis in the brain by muscarinic receptors. J. Neurochem. 52, 248-254.
33. Gulat-Marnay, C., Lafitte, A., Arrang, J. M. and Schwartz, J. C. (1989b) Modulation of histamine release and synthesis in the brain mediated by alpha 2-adrenoceptors. J. Neurochem. 53, 513-518.
34. Gulat-Marnay, C., Lafitte, A., Arrang, J. M. and Schwartz, J. C. (1990) Modulation of histamine release in the rat brain by kappa-opioid receptors. J. Neurochem. 55, 47-53.
35. Haas, H. L. (1984) Histamine potentiates neuronal excitation by blocking a calcium-dependent potassium conductance. Agents Actions 14, 534-537.
36. Haas, H. L. (1985) Histamine may act through cyclic AMP on hippocampal neurons. Agents Actions 16, 234-235.
37. Haas, H. L. and Greene, R. W. (1986) Effects of histamine on hippocampal pyramidal cells of the rat in vitro. Exp. Brain. Res. 62, 123-130.
38. Haller, E. and Binder, R. L. (1990) Clozapine and seizures. Am. J. Psychiatry 147, 1069-1071.
39. Hays, D. P., Johnson, B. F. and Perry, R. (1980) Prolonged hallucinations following a modest overdose of tripelennamine. Clin. Toxicol. 16, 331-333.
40. Hill, S. J., Daum, P. and Young, J. M. (1981) Affinities of H-1 antagonists in guinea pig brain: similarity of values determined from [s;3H] mepyramine binding and from inhibition of a functional response. J. Neurochem 37, 1257-1360.
41. Hill, S. J. (1990) Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmac. Rev. 42, 45-84.
42. Iinuma, K., Yokoyama, H., Otsuki, T., Yanai, K., Watanabe, T., Ido, T. and Itoh, M. (1993) Histamine H1 receptors in complex partial seizures [letter]. Lancet 341, 238.
43. Itil, T. M. and Soldatos, C. (1980) Epileptogenic side effects of psychotropic drugs. J. Am. Med. Assoc. 244, 1460-1463.
44. Itoh, Y., Oishi, R., Nishibori, M. and Saeki, K. (1985) Phencyclidine and the dynamics of mouse brain histamine. J. Pharmacol. Exp. Ther. 235, 788-792.
45. Itoh, Y., Oishi, R., Nishibori, M. and Saeki, K. (1988) Involvement of Mu receptors in the opioid-induced increase in the turnover of mouse brain histamine. J. Pharmacol. Exp. Ther. 244, 1021-1026.
46. Jacobs, B. L. (1987) How hallucinogenic drugs work. Am. Sci. 75, 386-392.
47. Javitt, D. C. and Zukin, S. R. (1991) Recent advances in the phencyclidine model of schizophrenia Am. J. Psychiatry 148, 1301-1308.
48. Javitt, D. C., Doneshka, P., Grochowski, S. and Ritter, W. (1995) Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia. Arch. Gen. Psychiatry 52, 550-558.
49. Johns, R. J. and Himwich, H. E. (1950) A central action of some antihistamines. Am. J. Psych. 107, 367-372.
50. Jones, I. H., Stevenson, J., Jordan, A., Connell, H. M., Hetherington, H. D. G. and Gibney, G. N. (1973) Pheniramine as an hallucinogen. Med. J. Aust. 1, 382-386.
51. Jones, J., Dougherty, J. and Cannon, L. (1986) Diphenhydramine-induced toxic psychosis. Amer. J. Emer. Med. 4, 369-371.
52. Jorgenson, K. L., Kow, L. M. and Pfaff, D. W. (1989) Histamine excites arcuate neurons in vitro through H1 receptors. Brain Res. 502, 171-179.
53. Kanba, S. and Richelson, E. (1984) Histamine H1 receptors in human brain labelled with [3H]doxepin. Brain Res. 304, 1-7.
54. Kanemoto, K., Kawasaki, J. and Kawai, I. (1994) Postictal psychoses: in comparison with acute interictal psychoses. Jpn. J. Psychiatry Neurol. 48, 209-211.
55. Khateb, A., Serafin, M. and Muhlethaler, M. (1990) Histamine excites pedunculopontine neurones in guinea pig brainstem slices. Neurosci. Lett. 112, 257-262.
56. King, G. and Weeks, S. D. (1965) Pyribenzamine activation of the electroencephalogram. Electroenceph. Clin. Neurophysiol. 18, 503-507.
57. Kiviranta, T., Tuomisto, L. and Airaksinen, E. M. (1995) Histamine in cerebrospinal fluid of children with febrile convulsions. Epilepsia 36, 276-280.
58. Koppel, C., Tenczer, J. and Ibe, K. (1987a) Poisoning with over-the-counter doxylamine preparations: an evaluation of 109 cases. Hum. Toxicol. 6, 355-359.
59. Koppel, C., Ibe, K. and Tenczer, J. (1987b) Clinical symptomatology of diphenhydramine overdose: an evaluation of 136 cases in 1982 to 1985. J. Toxicol. Clin. Toxicol. 25, 53-70.
60. Kostopoulos, G., Psarropoulou, C. and Haas, H. L. (1988) Membrane properties, response to amines and to tetanic stimulation of hippocampal neurons in the genetically epileptic mutant mouse tottering. Exp. Brain. Res. 72, 45-50.
61. Kubo, N., Shirakawa, O., Kuno, T. and Tanaka, C. (1987) Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay. Jpn. J. Pharmacol. 43, 277-282.
62. Lakoski, J. M. and Aghajanian, G. K. (1983) Effects of histamine H1- and H2-receptor antagonists on the activity of serotonergic neurons in the dorsal raphe nucleus. J. Pharm. Exper. Therap. 227, 517-523.
63. Landau, S. W., Nelson, W. A. and Gay, L. N. (1951) Antihistaminic properties of local anesthetics and anesthetic properties of antihistaminic compounds. J. Allergy 22, 19-30.
64. Langlais, P. J., Zhang, S. X., Weilersbacher, G., Hough, L. B. and Barke, K. E. (1994) Histamine-mediated neuronal death in a rat model of Wernicke's encephalopathy. J. Neurosci. Res. 38, 565-574.
65. Lee, K. H. and McCormick, D. A. (1995) Acetylcholine excites GABAergic neurons of the ferret perigeniculate nucleus through nicotinic receptors. J. Neurophysiol. 73, 2123-2128.
66. Lin, J. S., Sakai, K., Vanni-mercier, G. and Jouvet, M. (1989) A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res. 479, 225-240.
67. Litovitz, T. L., Felberg, L., White, S. and Klein-Schwartz, W. (1996) 1995 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am. J. Emerg. Med. 14, 487-537.
68. Logsdail, S. J. and Toone, B. K. (1988) Post-ictal psychoses. A clinical and phenomenological description. Br. J. Psychiatry 152, 246-252.
69. Lorenzon, N. M. and Foehring, R. C. (1992) Relationship between repetitive firing and afterhyperpolarizations in human neocortical neurons. J. Neurophysiology 67, 350-363.
70. Loring, D. W. and Meador, K. J. (1989) Central nervous system effects of antihistamines on evoked potentials. Ann. Allergy 63,
71. Malcolm, R. and Miller, W. C. (1962) Dimenhydrinate (Dramamine) abuse. Amer. J. Psychiatry 128, 126-127.
72. McCormick, D. A. (1989) GABA as an inhibitory neurotransmitter in human cerebral cortex. J. Neurophysiol. 62, 1018-1027.
73. McCormick, D. A. and Williamson, A. (1989) Convergence and divergence of neurotransmitter action in human cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 86, 8098-8102.
74. McCormick, D. A. and Williamson, A. (1991) Modulation of neuronal firing mode in cat and guinea pig LGNd by histamine: possible cellular mechanisms of histaminergic control of arousal. J. Neurosci. 11, 3188-3199.
75. McCormick, D. A. and Wang, Z. (1991) Serotonin and noradrenaline excite GABAergic neurons of the guinea-pig and cat nucleus reticularis thalami. J. Physiol. Lond. 442, 235-255.
76. McCormick, D. A. (1992a) Cellular mechanisms underlying cholinergic and noradrenergic modulation of neuronal firing mode in the cat and guinea pig dorsal lateral geniculate nucleus. J. Neurosci. 12, 278-289.
77. McCormick, D. A. (1992b) Neurotransmitter actions in the thalamus and cerebral cortex. J. Clin. Neurophysiol. 9, 212-223.
78. McCormick, D. A. (1992c) Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog. Neurobiol. 39, 337-388.
79. McCormick, D. A., Wang, Z. and Huguenard, J. (1993) Neurotransmitter control of neocortical neuronal activity and excitability. Cereb. Cortex 3, 387-398.
80. McNamara, J. O. (1994) Cellular and molecular basis of epilepsy. J. Neurosci. 14, 3413-3425.
81. Meldrum, B. S. (1992) Excitatory amino acids in epilepsy and potential novel therapies. Epilepsy Res. 12, 189-196.
82. Miller, J. W. (1992) The role of mesencephalic and thalamic arousal systems in experimental seizures. Prog. Neurobiol. 39, 155-178.
83. Miller, J. W., Gray, B. C. and Bardgett, M. E. (1992) Characterization of cholinergic regulation of seizures by the midline thalamus. Neuropharmacology 31, 349-356.
84. Miller, J. W., Gray, B. C., Turner, G. M. and Bardgett, M. E. (1993) An ascending seizure-controlling pathway in the medial brainstem and thalamus. Exp. Neurol. 121, 106-112.
85. Nicoll, R. A., Malenka, R. C. and Kauer, J. A. (1990) Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system. Physiol. Rev. 70, 514-565.
86. Nishibori, M., Oishi, R., Itoh, Y. and Saeki, K. (1986) Effects of GABA-mimetic drugs on turnover of histamine in the mouse brain. Jpn. J. Pharmacol. 41, 403-408.
87. Oishi, R., Nishibori, M., Itoh, Y. and Saeki, K. (1985) Delta-9-tetrahydrocannabinol decreases turnover of brain histamine. J. Pharmac. Exp. Ther. 232, 513-518.
88. Oishi, R., Nishibori, M., Itoh, Y. and Saeki, K. (1986) Diazepam-induced decrease in histamine turnover in mouse brain. Eur. J. Pharmacol. 124, 337-342.
89. Onodera, K., Tuomisto, L., Tacke, U. and Airaksinen, M. (1992) Strain differences in regional brain histamine levels between genetically epilepsy-prone and resistant rats. Methods Find. Exp. Clin. Pharmacol. 14, 13-16.
90. Onodera, K., Yamatodani, A., Watanabe, T. and Wada, H. (1994) Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog. Neurobiol. 42, 685-702.
91. Panula, P., Airaksinen, M. S., Pirvola, U. and Kotilainen, E. (1990) A histamine-containing neuronal system in human brain. Neurosci. 34, 127-132.
92. Pasternak, G. W. (1993) Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacology 16, 1-18.
93. Pennington, N. J. and Fox, A. P. (1994) Effects of LSD on Ca++ currents in central 5-HT-containing neurons: 5-HT1A receptors may play a role in hallucinogenesis. J. Pharmacol. Exp. Ther. 269, 1160-1165.
94. Pfeiffer, A., Brantl, V., Herz, A. and Emrich, H. (1986) Psychotomimesis mediated by k opiate receptors. Science 233, 774-776.
95. Phillis, J. W., Tebecis, A. K. and York, D. H. (1968) Histamine and some antihistamines: Their actions on cerebral cortical neurones. Br. J. Pharmac. Chemother. 33, 426-440.
96. Prell, G. D. and Green, J. P. (1986) Histamine as a neuroregulator. Ann. Rev. Neurosci. 9, 209-254.
97. Preston, K. L., Wolf, B., Guarino, J. J. and Griffiths, R. R. (1992) Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability. J. Pharmacol. Exper. Therap. 262, 707-720.
98. Rainnie, D. G., Grunze, H. C. R., McCarley, R. W. and Greene, R. W. (1994) Adenosine inhibition of mesopontine cholinergic neurons: Implications for EEG arousal. Science 263, 689-692.
99. Reiner, P. B. and Kamondi, A. (1994) Mechanisms of antihistamine-induced sedation in the human brain: H1 receptor activation reduces a background leakage potassium current. Neuroscience 59, 579-588.
100. Richelson, E. (1980) Psychotropic drugs and histamine H-1 receptors of cultured mouse neuroblastoma cells. Psychopharm. Bull. 16, 38-39.
101. Richmond, M. and Seger, D. (1985) Central anticholinergic syndrome in a child: a case report. J. Emer. Med. 3, 453-456.
102. Roman, D. (1972) Schizophrenia-like psychosis following 'Mandrax' overdose. Br. J. Psychiatry 121, 619-620.
103. Sakai, N., Sakurai, A., Sakurai, E. and Yanai, K. et al.. (1992) Effects of the histamine H3 receptor ligands thioperamide and (R)-alpha-methylhistamine on histidine decarboxylase activity of mouse brain. Biochem. Biophys. Res. Commun. 185, 121-126.
104. Sayer, R. J., Brown, A. M., Schwindt, P. C. and Crill, W. E. (1993) Calcium currents in acutely isolated human neocortical neurons. J. Neurophysiol. 69, 1596-1606.
105. Scherkl, R., Hashem, A. and Frey, H. H. (1991) Histamine in brain - its role in regulation of seizure susceptibility. Epilepsy Res. 10, 111-118.
106. Schlicker, E. (1988) H-3 receptor mediated inhibition of serotonin release in the rat brain cortex. Naunyn-Schmiedebergs Arch. Pharm. 337, 588-590.
107. Schlicker, E., Malinowska, B., Kathmann, M. and Gothert, M. (1994) Modulation of neurotransmitter release via histamine H3 heteroreceptors. Fundam. Clin. Pharmacol. 8, 128-137.
108. Schwartz, J. C., Arrang, J. M., Garbarg, M., Pollard, H. and Ruat, M. (1991) Histaminergic transmission in the mammalian brain. Physiol. Rev. 71, 1-51.
109. Schwartzkroin, P. A. (1994) Cellular electrophysiology of human epilepsy. Epilepsy Res. 17, 185-192.
110. Sherin, J. E., Shiromani, P. J., McCarley, R. W. and Saper, C. B. (1996) Activation of ventrolateral preoptic neurons during sleep. Science 271, 216-219.
111. Shimoda, Y., Koizumi, A. and Tanaka, K. (1960) Electroencephalographic activation of "diencephalic epilepsy" with diphenhydramine. Yonago. Acta. Med. 4, 99-102.
112. Simons, F. E. R. (1994) H1-receptor antagonists. Drug Safety 10, 350-380.
113. Soleymanikashi, Y. and Weiss, N. S. (1970) Antihistaminic reactions: a review and presentation of two unusual examples. Ann. Allergy 28, 486-491.
114. Souza, V. B., Muir, W. J., Walker, M. T., Glabus, M. F., Roxborough, H. M., Sharp, C. W., Dunan, J. R. and Blackwood, D. H. (1995) Auditory P300 event-related potentials and neuropsychological performance in schizophrenia and bipolar affective disorder. Biol. Psychiatry 37, 300-310.
115. Spreeg, K. V., Wang, S., Avant, G. R., Parker, R. and Schenker, S. (1981) In vitro antagonism of benzodiazepine binding to cerebral receptors by H1 and H2 antihistamines. J. Lab. Clin. Med. 97, 112-122.
116. Squires, R. F. and Saederup, E. (1991) A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of functional psychosis. Neurochem. Res. 16, 1099-1111.
117. Steriade, M., Datta, S., Pare, D., Oakson, G. and Curro Dossi, R. C. (1990) Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems. J. Neurosci. Aug 10, 2541-2559.
118. Steriade, M., McCormick, D. A. and Sejnowski, T. J. (1993) Thalamocortical oscillations in the sleeping and aroused brain. Science 262, 679-685.
119. Takemura, M., Yamatodani, A. and Wada, H. (1989) Inhibition of histamine release from rat hypothalamic slices by omega-conotoxin GVIA, but not by nilvadipine, a dihydropyridine derivative. Brain Res. 496, 351-356.
120. Tasaka, K., Chung, Y. H., Sawada, K. and Mio, M. (1989) Excitatory effect of histamine on the arousal system and its inhibition by H1 blockers. Brain Res. Bull. 22, 271-275.
121. Ter Laak, A. M., Donne-Op den Kelder, G. M., Bast, A. and Timmerman, H. (1993) Is there a difference in the affinity of histamine H1 receptor antagonists for CNS and peripheral receptors? An in vitro study. Eur. J. Pharmacol. 232, 199-205.
122. Traynelis, S. F., Hartley, M. and Heinemann, S. F. (1995) Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science 268, 873-876.
123. Trimble, M. R. (1977) The relationship between epilepsy and schizophrenia. Biol. Psychiat. 12, 299-304.
124. Tuomisto, L. and Tacke, U. (1986) Is histamine an anticonvulsive inhibitory transmitter?. Neuropharmacol. 25, 955-958.
125. Uteshev, V., Stevens, D. R. and Haas, H. L. (1995) A persistent sodium current in acutely isolated histaminergic neurons from rat hypothalamus. Neurosci. 66, 143-149.
126. Uzan, A. (1979) Are antihistamines sedative via a blockade of brain H1-receptors. J. Pharm. Pharmacol. 31, 701.
127. von Krosigk, M., Bal, T. and McCormick, D. A. (1993) Cellular mechanisms of a synchronized oscillation in the thalamus. Science 261, 361-364.
128. Vorobjev, V. S., Sharonova, I. N., Walsh, I. B. and Haas, H. L. (1993) Histamine potentiates N-methyl-D-aspartate responses in acutely isolated hippocampal neurons. Neuron 11, 837-844.
129. Wada, H., Inagaki, N., Yamatodani, A. and Watanabe, T. (1991) Is the histaminergic neuron system a regulatory center for whole-brain activity?. Trends Neurosci. 14, 415-418.
130. Wallace, R. M. and Young, J. M. (1983) Temperature dependence of the binding of [3H]mepyramine and related compounds to the histamine H1 receptor. Mol. Pharmacol. 23, 60-66.
131. Wang, Z. and McCormick, D. A. (1993) Control of firing mode of corticotectal and corticopontine layer V burst-generating neurons by norepinephrine, acetylcholine, and 1S, 3R-ACPD. J. Neurosci. 13, 2199-2216.
132. White, J. M. (1985) The discriminative stimulus properties of mepyramine. Life Sci. 37, 1145-1153.
133. Whittington, M. A., Traub, R. D. and Jeffreys, J. G. R. (1995) Synchronized oscillations in interneuronal networks driven by metabotropic glutamate receptor activation. Nature 373, 612-615.
134. Woodrow, C. H. and Way, E. L. (1951) Barbiturate antagonism of antihistamine overdose. Fed. Proc. 10, 308.
135. Wyngarden, J. B. and Seevers, M. H. (1951) The toxic effects of antihistaminic drugs. J. Am. Med. Assoc. 145, 277-282.
136. Yanai, K., Watanabe, T., Yokoyama, H., Meguro, K., Hatazawa, J., Itoh, M., Iwata, R., Ishiwata, K., Takahashi, T. and Ido, T. (1992a) Histamine H1 receptors in human brain visualized in vivo by [11C]doxepin and positron emission tomography. Neurosci. Lett. 137, 145-148.
137. Yanai, K., Watanabe, T., Yokoyama, H., Hatazawa, J., Iwata, R., Ishiwata, K., Meguro, K., Itoh, M., Takahashi, T. and Ido, T. et al.. (1992b) Mapping of histamine H1 receptors in the human brain using [11C]pyrilamine and positron emission tomography. J. Neurochem. 59, 128-136.
138. Yanovsky, Y., Reymann, K. and Haas, H. L. (1995) pH-dependent facilitation of synaptic transmission by histamine in the CA1 region of mouse hippocampus. Eur. J. Neurosci. 7, 2017-2020.
139. Yokoyama, H., Onodera, K., Maeyama, K., Yanai, K., Iinuma, K., Tuomisto, L. and Watanabe, T. (1992) Histamine levels and clonic convulsions of electrically-induced seizure in mice: the effects of alpha-fluoromethylhistidine and metoprine. Naunyn-Schmiedebergs Arch. Pharmac. 346, 40-45.
140. Yokoyama, H., Iinuma, K., Yanai, K., Watanabe, T., Sakurai, E. and Onodera, K. (1993a) Proconvulsant effect of ketotifen, a histamine H1 antagonist, confirmed by the use of D-chlorpheniramine with monitoring electroencephalography. Methods Find. Exp. Clin. Pharmacol. 15, 183-188.
141. Yokoyama, H., Onodera, K., Iinuma, K. and Watanabe, T. (1993b) Effect of thioperamide, a histamine H3 receptor antagonist, on electrically induced convulsions in mice. Eur. J. Pharmacol. 234, 129-133.
142. Yokoyama, H., Onodera, K., Iinuma, K. and Watanabe, T. (1993c) Proconvulsive effects of histamine H1-antagonists on electrically-induced seizure in developing mice. Psychopharmacology 112, 199-203.
143. Yokoyama, H., Onodera, K., Iinuma, K. and Watanabe, T. (1994a) 2-Thiazolylethylamine, a selective histamine H1 agonist, decreases seizure susceptibility in mice. Pharmacol. Biochem. Behav. 47, 503-507.
144. Yokoyama, H., Onodera, K., Maeyama, K., Sakurai, E., Iinuma, K., Leurs, R., Timmerman, H. and Watanabe, T. (1994b) Clobenpropit (VUF-9153), a new histamine H3 receptor antagonist, inhibits electrically induced convulsion in mice. Eur. J. Pharmacol. 260, 23-28.
145. Young, C. S., Mason, R. and Hill, S. J. (1988) Inhibition by H-1 antihistamines of the uptake of noradrenaline and 5-HT into rat brain synaptosomes. Biochem. Pharmacol. 37, 976-978.